Clarametyx Chief Scientific Officer Chuck McOsker participated in the 2021 NCH Technology Showcase hosted by the Office of Technology Commercialization at Nationwide Children’s Hospital. During his presentation, Dr. McOsker provided a closer look at the Clarametyx humanized monoclonal antibody in development as a novel approach to biofilm-related infections.
